中药专利复方治疗慢性阻塞性肺疾病的用药规律研究*
作者:
作者单位:

(1. 广州中医药大学第一临床医学院,广东 广州 510405;2. 佛山市中医院,广东 佛山52800; 3. 广州中医药大学第一附属医院,广东 广州 510405)

作者简介:

通讯作者:

中图分类号:

R259

基金项目:

收稿日期: 2021 - 03- 18 基金项目: 广州市科技计划项目(202102010479);广州中医药大学院内制剂开发项目(2019ZJ06) 第一作者简介: 邓银河(1994-),女,在读硕士研究生,研究方向:中医药防治呼吸系统疾病。 通信作者: 刘琼,E-mail:1423254686@qq.com


Analysis of Medication Rules of Traditional Chinese Medicine Patent Compound Prescriptions in Treating Chronic Obstructive Pulmonary Disease
Author:
Affiliation:

(1. The First Clinical Medical College, Guangzhou University of Chinese Medicine, Guangzhou 510405,China; 2. Foshan Hospital of TCM, Foshan 52800,China; 3. The First Affiliated Hospital of Guangzhou University of Chinese Medicine, Guangzhou 510405,China)

Fund Project:

  • 摘要
  • |
  • 图/表
  • |
  • 访问统计
  • |
  • 参考文献
  • |
  • 相似文献
  • |
  • 引证文献
  • |
  • 资源附件
  • |
    摘要:

    目的 分析中医药专利复方治疗慢性阻塞性肺疾病的组方规律。方法 检索国家知识产权局专利检索及分析系统中治疗慢性阻塞性肺疾病的中药复方,借助中医传承辅助平台V2.5运用Apriori算法、关联规则、复杂系统熵聚类法等对所收集专利处方进行统计分析。结果 共录入86首中药专利复方,包含313味中药。其中高频药物有黄芪、杏仁、贝母等;高频药对组合多以益气健脾、益气活血、化痰止咳为主要配伍模式;获得5首新方组合。结论 中药专利复方治疗慢性阻塞性肺疾病多从肺脾肾论治,益肺健脾以止咳化痰,活血化瘀、通络平喘、补肾益精;主要病机为肺脾肾亏虚,痰瘀互结。本研究为慢阻肺的临床治疗及新药研发提供一定参考意义。

    Abstract:

    Objective To analyze the medication rule of traditional Chinese medicine compound prescription for chronic obstructive pulmonary disease(CPOD). Methods The Chinese medicine compound prescriptions for COPD were retrieved by searching Patent Search and Analysis of SIPO. Then the data were put into the TCMISS V2.5 and Apriori algorithm, association rules and entropy clustering method of complex system were used for data analysis. Results A total of 86 patented formulations were input,including 313 medicinal materials. For the prescriptions of COPD,single ingredient with high frequency included Astragalus membranaceus,Apricot kernel, Fritillaria Thun-bergli and so on. The main compatibility of the drug model is to invigorate lung and spleen,invigorate Qi and activate blood circulation, and relieve cough and reduce sputum. At last, 5 new prescriptions were got. Conclusion The main treatment methods in TCM patented formulations for COPD are mainly based on the treatment of lung, spleen and kidney, focus on invigorating the lung and spleen to relieve cough and phlegm, activating blood circulation to remove blood stasis, smoothing asthma and nourishing the kidney. And the deficiency of lung, spleen and kidney and the interaction of phlegm and blood stasis is the main pathogenesis of COPD. This study provides certain reference for the clinical treatment of COPD and the research and development of new drugs.

    参考文献
    相似文献
    引证文献
引用本文
分享
文章指标
  • 点击次数:
  • 下载次数:
  • HTML阅读次数:
  • 引用次数:
历史
  • 收稿日期:
  • 最后修改日期:
  • 录用日期:
  • 在线发布日期:
  • 出版日期:

温馨提示

关闭